The effect of kidney volume estimation on dosimetry in lutetium-177 DOTATATE therapy.

Authors
Matthews, Lucy F
Jones, Ivor W
Affiliation
Department of Nuclear Medicine (CMPE), The Christie NHS Foundation Trust, Manchester
Issue Date
2018-03-09

Metadata
Show full item record
Abstract
The kidneys are the dose-limiting organ in lutetium-177 DOTATATE therapy. Therefore, it is advisable to perform critical organ dosimetry focussed on renal dose in treated patients. A key uncertainty in such dose estimates is the use of standard phantoms to represent the individual patient. The primary aim of this study was to investigate the accuracy of methods for estimating kidney size, and hence absorbed kidney dose, by comparison with individual measurements from computed tomography (CT) imaging.
Citation
The effect of kidney volume estimation on dosimetry in lutetium-177 DOTATATE therapy. 2018, Nucl Med Commun
Journal
Nuclear Medicine Communications
URI
http://hdl.handle.net/10541/620909
DOI
10.1097/MNM.0000000000000821
PubMed ID
29528911
Type
Article
Language
en
ISSN
1473-5628
Collections